<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Analgesic Indications: Developing Drug and Biological Products; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Analgesic Indications: Developing Drug and Biological Products; Availability</h1>
    <p class="timestamp">Published: 2014-02-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Analgesic Indications: Developing Drug and Biological Products." This guidance provides recommendations to sponsors on the development of prescription drugs for the management of acute and chronic pain, as well as the management of breakthrough pain. Specifically, this guidance focuses on drug development and trial design issues and chemistry, manufacturing, and controls concerns that...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-02557</p>
    <p><strong>Publication Date:</strong> 2014-02-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/02/06/2014-02557/draft-guidance-for-industry-on-analgesic-indications-developing-drug-and-biological-products">https://www.federalregister.gov/documents/2014/02/06/2014-02557/draft-guidance-for-industry-on-analgesic-indications-developing-drug-and-biological-products</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-02557</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
